CHINOOK THERAPEUTICS INC - COM (KDNY)

CUSIP: 16961L106

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
23,823,117
Share change
+18,332,870
Total reported value
$377,870,890
Put/Call ratio
245%
Price per share
$15.86
Number of holders
75
Value change
+$291,044,585
Number of buys
66
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 16961L106?
CUSIP 16961L106 identifies KDNY - CHINOOK THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHINOOK THERAPEUTICS INC - COM (KDNY) as of Q4 2020

As of 31 Dec 2020, CHINOOK THERAPEUTICS INC - COM (KDNY) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,823,117 shares. The largest 10 holders included ATP Life Science Ventures, L.P., Samsara BioCapital, LLC, BlackRock Inc., ORBIMED ADVISORS LLC, EcoR1 Capital, LLC, Vivo Capital, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., FMR LLC, and BAILLIE GIFFORD & CO. This page lists 75 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.